LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 110 filers reported holding LIGAND PHARMACEUTICALS INC in Q2 2013. The put-call ratio across all filers is 0.86 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $1,245,198 | +202.4% | 20,781 | +263.8% | 0.00% | +100.0% |
Q2 2023 | $411,835 | -48.3% | 5,712 | -47.3% | 0.00% | 0.0% |
Q1 2023 | $797,023 | +213.0% | 10,835 | +184.2% | 0.00% | – |
Q4 2022 | $254,642 | -100.0% | 3,812 | -77.4% | 0.00% | -100.0% |
Q3 2022 | $1,453,020,000 | +280.4% | 16,874 | +294.2% | 0.00% | +100.0% |
Q2 2022 | $381,951,000 | -32.7% | 4,281 | -15.1% | 0.00% | 0.0% |
Q1 2022 | $567,287,000 | -64.0% | 5,043 | -50.6% | 0.00% | -50.0% |
Q4 2021 | $1,576,573,000 | -34.8% | 10,207 | -41.2% | 0.00% | -33.3% |
Q3 2021 | $2,416,645,000 | +476.7% | 17,346 | +443.1% | 0.00% | +200.0% |
Q2 2021 | $419,021,000 | -26.4% | 3,194 | -14.5% | 0.00% | 0.0% |
Q1 2021 | $569,706,000 | +164.0% | 3,737 | +72.2% | 0.00% | – |
Q4 2020 | $215,806,000 | +5.0% | 2,170 | +0.6% | 0.00% | – |
Q3 2020 | $205,510,000 | -36.9% | 2,156 | -25.9% | 0.00% | -100.0% |
Q2 2020 | $325,595,000 | -69.8% | 2,911 | -80.4% | 0.00% | -50.0% |
Q1 2020 | $1,078,292,000 | +211.6% | 14,828 | +346.9% | 0.00% | +100.0% |
Q4 2019 | $346,034,000 | -1.9% | 3,318 | -6.4% | 0.00% | 0.0% |
Q3 2019 | $352,670,000 | +40.4% | 3,543 | +61.0% | 0.00% | 0.0% |
Q2 2019 | $251,244,000 | -54.6% | 2,201 | -50.0% | 0.00% | 0.0% |
Q1 2019 | $552,998,000 | +217.4% | 4,399 | +242.6% | 0.00% | – |
Q4 2018 | $174,239,000 | -82.6% | 1,284 | -64.8% | 0.00% | -100.0% |
Q3 2018 | $1,002,163,000 | +113.1% | 3,651 | +60.8% | 0.00% | 0.0% |
Q2 2018 | $470,276,000 | -57.6% | 2,270 | -66.2% | 0.00% | -50.0% |
Q1 2018 | $1,110,040,000 | -6.0% | 6,721 | -22.0% | 0.00% | 0.0% |
Q4 2017 | $1,180,610,000 | -20.0% | 8,622 | -20.5% | 0.00% | -50.0% |
Q3 2017 | $1,476,411,000 | +97.3% | 10,844 | +76.0% | 0.00% | +100.0% |
Q2 2017 | $748,188,000 | +2.1% | 6,163 | -10.5% | 0.00% | 0.0% |
Q1 2017 | $732,729,000 | +16.7% | 6,883 | +13.8% | 0.00% | -33.3% |
Q4 2016 | $628,012,000 | +103.9% | 6,046 | +100.3% | 0.00% | +200.0% |
Q3 2016 | $308,017,000 | -56.4% | 3,018 | -49.0% | 0.00% | -66.7% |
Q2 2016 | $706,078,000 | +161.6% | 5,920 | +134.9% | 0.00% | +200.0% |
Q1 2016 | $269,867,000 | -48.2% | 2,520 | -47.5% | 0.00% | 0.0% |
Q4 2015 | $520,632,000 | +71.3% | 4,802 | +35.3% | 0.00% | 0.0% |
Q3 2015 | $303,886,000 | +106.3% | 3,548 | +143.0% | 0.00% | – |
Q2 2015 | $147,314,000 | +310.0% | 1,460 | +213.3% | 0.00% | – |
Q1 2015 | $35,933,000 | -86.2% | 466 | -91.6% | 0.00% | – |
Q3 2014 | $260,231,000 | +17306.8% | 5,538 | +22975.0% | 0.00% | – |
Q2 2014 | $1,495,000 | -87.6% | 24 | -89.6% | 0.00% | – |
Q4 2013 | $12,098,000 | -94.2% | 230 | -95.2% | 0.00% | – |
Q3 2013 | $207,181,000 | -10.3% | 4,787 | -22.5% | 0.00% | – |
Q2 2013 | $231,068,000 | – | 6,175 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 2,626,160 | $138,136,000 | 24.17% |
KNOTT DAVID M | 1,292,566 | $67,988,972,000 | 13.87% |
GROW Partners, LLC | 200,000 | $10,520,000 | 6.41% |
Opaleye Management Inc. | 90,000 | $4,860,000,000 | 3.82% |
OBERWEIS ASSET MANAGEMENT INC/ | 213,317 | $11,220,000 | 2.72% |
First Light Asset Management, LLC | 60,242 | $3,169,000 | 2.69% |
Timpani Capital Management LLC | 98,956 | $5,205,000 | 2.59% |
Iguana Healthcare Management, LLC | 75,000 | $3,945,000 | 2.25% |
Eventide Asset Management | 134,400 | $7,069,000 | 2.18% |
ASHFORD CAPITAL MANAGEMENT INC | 215,223 | $11,321,000 | 2.16% |